Deutsche Bank’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Sell |
57,730
-13,167
| -19% | -$94.5K | ﹤0.01% | 2537 |
|
|
2025
Q1 | $425K | Sell |
70,897
-8,368
| -11% | -$50.1K | ﹤0.01% | 2542 |
|
|
2024
Q4 | $618K | Sell |
79,265
-83,593
| -51% | -$652K | ﹤0.01% | 2472 |
|
|
2024
Q3 | $1.76M | Sell |
162,858
-75,582
| -32% | -$816K | ﹤0.01% | 1806 |
|
|
2024
Q2 | $2.01M | Sell |
238,440
-486
| -0.2% | -$4.1K | ﹤0.01% | 1612 |
|
|
2024
Q1 | $1.61M | Buy |
238,926
+201,491
| +538% | +$1.35M | ﹤0.01% | 1745 |
|
|
2023
Q4 | $220K | Sell |
37,435
-599
| -2% | -$3.52K | ﹤0.01% | 2783 |
|
|
2023
Q3 | $371K | Buy |
38,034
+9,106
| +31% | +$88.8K | ﹤0.01% | 2338 |
|
|
2023
Q2 | $343K | Sell |
28,928
-14,971
| -34% | -$177K | ﹤0.01% | 2570 |
|
|
2023
Q1 | $474K | Buy |
43,899
+8,628
| +24% | +$93.1K | ﹤0.01% | 2524 |
|
|
2022
Q4 | $408K | Buy |
35,271
+8,456
| +32% | +$97.8K | ﹤0.01% | 2554 |
|
|
2022
Q3 | $400K | Buy |
26,815
+5,725
| +27% | +$85.4K | ﹤0.01% | 2494 |
|
|
2022
Q2 | $190K | Buy |
21,090
+913
| +5% | +$8.23K | ﹤0.01% | 3189 |
|
|
2022
Q1 | $151K | Sell |
20,177
-2,398
| -11% | -$17.9K | ﹤0.01% | 3383 |
|
|
2021
Q4 | $194K | Buy |
22,575
+1,202
| +6% | +$10.3K | ﹤0.01% | 3368 |
|
|
2021
Q3 | $180K | Sell |
21,373
-687
| -3% | -$5.79K | ﹤0.01% | 3585 |
|
|
2021
Q2 | $179K | Buy |
+22,060
| New | +$179K | ﹤0.01% | 3804 |
|
|
2020
Q1 | – | Sell |
-2,433
| Closed | -$7K | – | 4163 |
|
|
2019
Q4 | $7K | Buy |
2,433
+2,258
| +1,290% | +$6.5K | ﹤0.01% | 4346 |
|
|
2019
Q3 | $1K | Sell |
175
-7,170
| -98% | -$41K | ﹤0.01% | 4503 |
|
|
2019
Q2 | $75K | Sell |
7,345
-15,071
| -67% | -$154K | ﹤0.01% | 4176 |
|
|
2019
Q1 | $391K | Buy |
22,416
+6,502
| +41% | +$113K | ﹤0.01% | 3542 |
|
|
2018
Q4 | $279K | Buy |
15,914
+6,452
| +68% | +$113K | ﹤0.01% | 3612 |
|
|
2018
Q3 | $389K | Buy |
9,462
+7,364
| +351% | +$303K | ﹤0.01% | 3855 |
|
|
2018
Q2 | $120K | Buy |
+2,098
| New | +$120K | ﹤0.01% | 4315 |
|